Teva to buy Allergan's generics business for $40.5B
July 27, 2015 at 07:38 AM EDT
Israel's Teva Pharmaceutical will buy Allergan's generic pharmaceuticals business for $40.5 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |